New Lung Cancer Classification Model Shows Promise
The first-generation lung cancer classification model based on gene expression data is already available for use within Qlucore Insights.
Read MorePosted by Melanie Hamilton-Basich | May 30, 2023 | Lung Cancer |
The first-generation lung cancer classification model based on gene expression data is already available for use within Qlucore Insights.
Read MorePosted by Chris Wolski | May 29, 2023 | Cancer |
Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases.
Read MorePosted by Melanie Hamilton-Basich | May 26, 2023 | Hematology & Serology, Lung Cancer |
A new class of blood-based biomarkers could be developed into improved or orthogonal tests for predicting tumor responses to treatment.
Read MorePosted by Chris Wolski | May 25, 2023 | Lung Cancer |
OncoHost will give a poster presentation demonstrating the accuracy of its PROphet biomarker model at the upcoming 2023 ASCO Annual Meeting.
Read MorePosted by Melanie Hamilton-Basich | May 12, 2023 | Lung Cancer |
The first lung nodule biopsy procedure using Serpex’s Compass steerable needle guided by Body Vision Medical’s LungVision CT imaging system was used to successfully diagnose a small peripheral nodule in the right lower lobe of the patient’s lung.
Read More